Lorazepam Injection shortage
Current 11 presentations · 4 manufacturers · first FDA posting 2018-05-03 · last update 2026-10-15
Manufacturers: Amphastar Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Demand increase for the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) | Amphastar Pharmaceuticals, Inc. | Current Available |
— | Posted 05/03/2018 Updated 10/05/2026 | |
| Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 05/03/2018 Updated 10/15/2026 |
| Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 09/05/2018 Updated 10/14/2026 |
| Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted 09/05/2018 Updated 09/18/2026 |
| Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 09/05/2018 Updated 10/14/2026 |
| Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 09/05/2018 Updated 09/18/2026 |
| Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted 09/05/2018 Updated 09/18/2026 |
| Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 09/05/2018 Updated 09/18/2026 |
| Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 09/05/2018 Updated 10/14/2026 |
| Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 05/03/2018 Updated 10/14/2026 |
| Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: June 2027; Estimated Recovery: December 2027 | Posted 05/03/2018 Updated 10/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)